BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurwitz D. Repurposing current therapeutics for treating COVID-19: A vital role of prescription records data mining. Drug Dev Res 2020;81:777-81. [PMID: 32420637 DOI: 10.1002/ddr.21689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zong N, Wen A, Moon S, Fu S, Wang L, Zhao Y, Yu Y, Huang M, Wang Y, Zheng G, Mielke MM, Cerhan JR, Liu H. Computational drug repurposing based on electronic health records: a scoping review. NPJ Digit Med 2022;5:77. [PMID: 35701544 DOI: 10.1038/s41746-022-00617-6] [Reference Citation Analysis]
2 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
3 Baristaite G, Gurwitz D. Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells. Drug Dev Res 2022. [PMID: 35103351 DOI: 10.1002/ddr.21923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Elkahloun AG, Saavedra JM. Candesartan could ameliorate the COVID-19 cytokine storm. Biomed Pharmacother 2020;131:110653. [PMID: 32942152 DOI: 10.1016/j.biopha.2020.110653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 Rex DAB, Arun Kumar ST, Modi PK, Keshava Prasad TS. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target? OMICS 2021;25:408-16. [PMID: 34191617 DOI: 10.1089/omi.2021.0080] [Reference Citation Analysis]
6 Valipour M, Irannejad H, Emami S. Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs). Drug Dev Res 2022. [PMID: 35706384 DOI: 10.1002/ddr.21961] [Reference Citation Analysis]
7 Xiang Y, Wong KC, So HC. Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities. Pharmaceutics 2021;13:1514. [PMID: 34575590 DOI: 10.3390/pharmaceutics13091514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Luo W, Ding R, Guo X, Zhan T, Tang T, Fan R, Wang Y. Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3. Comput Biol Med 2022;145:105457. [PMID: 35366469 DOI: 10.1016/j.compbiomed.2022.105457] [Reference Citation Analysis]
9 Dogan O, Tiwari S, Jabbar MA, Guggari S. A systematic review on AI/ML approaches against COVID-19 outbreak. Complex Intell Systems 2021;:1-24. [PMID: 34777970 DOI: 10.1007/s40747-021-00424-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Aronskyy I, Masoudi-Sobhanzadeh Y, Cappuccio A, Zaslavsky E. Advances in the computational landscape for repurposed drugs against COVID-19. Drug Discov Today 2021:S1359-6446(21)00335-4. [PMID: 34339864 DOI: 10.1016/j.drudis.2021.07.026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Hsieh KL, Wang Y, Chen L, Zhao Z, Savitz S, Jiang X, Tang J, Kim Y. Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation. Res Sq 2020:rs. [PMID: 33330858 DOI: 10.21203/rs.3.rs-114758/v1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Akula SM, Abrams SL, Steelman LS, Candido S, Libra M, Lerpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Blalock WL, Piazzi M, Montalto G, Cervello M, Notarbartolo M, Basecke J, McCubrey JA. Cancer therapy and treatments during COVID-19 era. Adv Biol Regul 2020;77:100739. [PMID: 32773105 DOI: 10.1016/j.jbior.2020.100739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]